Comparative study of assortment of medical films presented in the pharmaceutical markets of Ukraine, USA and Poland

Keywords: medical films, transdermal therapeutic systems, analysis of assortment

Abstract

The development of medical films containing active substances immobilized on polymeric carriers become significantly popular in the world. Medical films belong to the application forms and designed for injection of active pharmaceutical ingredients through the skin, periodontal tissue, the mucous membrane of the mouth. There are transdermal therapeutic systems, including buccal, dental and oral films. Pharmaceutical manufacturers present a wide range of medicinal films containing various active ingredients on the world market.

The purpose of our study was to conduct a comparison of the range of medicines in the form of medical films registered in the pharmaceutical markets of Ukraine, USA, and Poland. The object of the study was information on registered drugs in Ukraine, the USA, and Poland. The applied methods of study include generalization, systematization, and comparative analysis.

The range of medicinal films presented in the pharmaceutical markets of Ukraine, the USA, and Poland is analyzed. It is found that as of November 2019, there were 24 medicinal films registered in Ukraine, 70 medicinal films in Poland, and 104 medicinal films in the USA. Medicines in the form of transdermal therapeutic systems or patches have been registered in the pharmaceutical market of Ukraine. No buccal and oral drug films have been registered. In the Ukrainian market medicinal films are exclusively represented by foreign manufacturers from Germany (65%), Ireland (10%), Belgium (10%), Greece (5%), United Kingdom (5%), and the United States (5%).

The largest range of medical films is presented in the USA: 89.2% transdermal films, 7.8% – buccal films, 2.9% – oral films. In the Polish market, transdermal therapeutic systems also account for the largest share, with only 3% of the range being buccal films. In this study, we found that the active substances such as fentanyl, buprenorphine, estradiol, nicotine, nitroglycerin, rivastigmine, rotigotine, testosterone, scopolamine, oxybutynin, and others are most often introduced into drug films. It is found that in the US market the share of domestic manufacturers of medical films is 55.79%. Ukrainian pharmaceutical manufacturers do not offer medical films, which is a prerequisite for the development of those domestic dosage forms.

References

1. Sandeep Karkia, Hyeongmin Kim, Seon-Jeong Na et al. Thin films as an emerging platform for drug delivery // Asian J. Pharmac. Sci. – 2016. – V. 11, Is. 5. – P. 559–574. https://doi.org/10.1016/j.ajps.2016.05.004

2. Kathpalia H., Patil A. Formulation and evaluation of orally disintegrating films of levocetirizine dihydrochloride // Indian J. Pharm. Sci. – 2017. – V. 79 (2). – P. 204–211.

3. Derzhavna Farmakopeia Ukrainy: v 3 t. / Ukr. nauk. farmakopeinui tsentr yakosti likarskykh zasobiv. – 2 vyd. – Kharkiv: DP «Ukr. nauk. farmakopeinui tsentr yakosti likarskykh zasobiv», 2015. – Т. 1. – 1128 s.

4. Irfan M., Rabel S., Bukhtar Quratulain et al. Orally disintegrating films: A modern expansion in drug delivery system // Saudi Pharmac. J. –2016. – V. 24, Is. 5. – P. 537–546. https://doi.org/10.1016/j.jsps.2015.02.024

5. Vlasenko I. O., Davtian L. L. Zastosuvannia polimeriv u tekhnolohii likarskykh plivok // Zb. nauk. prats spivrob. NMAPO imeni P. L. Shupyka. – К., 2013. – Vyp. 22, Кn. 4. – S. 369–376.

6. Davtian L. L., Vlasenko I. O., Dultseva O. V. ta in. Doslidzhennia sposobu vvedennia nanochastok u osnovu polimernykh plivok // Zb. nauk. prats «Problemy viiskovoi okhorony zdorovia». – 2012. – Vyp. 31. – S. 315–319.

7. Gunjan Shrivastava, Pankaj Kumar Singh, Roshni Fatima Rizvi et al. A novel approach for buccal drug delivery system – fast dissolving film // World j. pharmacy and pharmaceutical sci. – 2015. – Iss. 4 (10). – P. 1744–1760.

8. Tymchenko I. M., Davtian L. L., Vlasenko I. O. ta in. Obgruntuvannia farmakokinetychnykh pokaznykiv likarskykh plivok dlia zadach matematychnogo modeliuvannia // Med. informatyka ta inzheneriia. – 2011. – № 1. – S. 45–47.

9. Himansu Bhusan Samal, Itishree Jogamaya Das, Ch. Niranjan Patra et al. Design and in vitro evaluation of curcumin dental films for the treatment of periodontitis // Asian J. Pharmac. – 2017 (Suppl). – N 11 (3). – Р. 579–587.

10. Mahboob M. B. H., Riaz T., Jamshaid M. et al. Oral Films: A Comprehensive Review // Inter. Current Pharmac. J. – 2016. – V. 5 (12). – P. 111–117.

11. Globalnyy farmrinok cherez 5 let: prognoz do 2023 g. Retrieved from: https://www.apteka.ua/article/497978

12. The European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures, 2019. EFPIA Retrieved from: https://www.efpia.eu/media/412931/the-pharmaceutical-industry-in-figures-2019.pdf

13. Ministry of Health of Ukraine. Normatyvno-dyrektyvni dokumenty MOZ Ukrainy. Retrieved from: http://mozdocs.kiev.ua

14. Sait «Centrum Informacji o Leku». Retrieved from: http://leki-informacje.pl/rejestracje

15. Onlayn dovidnyk. Pharmindex. Retrieved from: http://pharmindex.pl

16. U. S. Drug and Food Administration Retrieved from: https://www.accessdata.fda.gov.
Published
2020-03-11
How to Cite
Demchuk, M. B., Groshovyi, T. A., & Malanchyk, N. V. (2020). Comparative study of assortment of medical films presented in the pharmaceutical markets of Ukraine, USA and Poland. Farmatsevtychnyi Zhurnal, (1), 12-19. https://doi.org/10.32352/0367-3057.1.20.02
Section
Management of pharmacy